Publications by authors named "Josan Gandawijaya"

The neuronal cell adhesion molecule contactin-4 () is genetically associated with autism spectrum disorder (ASD) and other psychiatric disorders. -deficient mouse models have previously shown that CNTN4 plays important roles in axon guidance and synaptic plasticity in the hippocampus. However, the pathogenesis and functional role of CNTN4 in the cortex has not yet been investigated.

View Article and Find Full Text PDF

The human SH-SY5Y neuroblastoma cell line is widely used in neuroscience research as a neuronal cell model. Following differentiation to a neuron-like state, SH-SY5Y cells become more morphologically similar to neurons and form functional synapses. Previous studies have managed to differentiate SH-SY5Y cells towards cholinergic, dopaminergic and adrenergic fates.

View Article and Find Full Text PDF
Article Synopsis
  • HIF-PHIs are being developed to treat anemia in CKD, but it's crucial to ensure they are safe for the heart.
  • Genetic variants can potentially predict the risk of adverse cardiovascular effects from these treatments.
  • A specific genetic variant related to EPO levels was identified and tested, showing no increased risk of coronary artery disease, heart attack, or stroke with higher EPO levels, indicating a safer profile for these therapies.
View Article and Find Full Text PDF

Autism spectrum disorder (ASD) is a complex neurodevelopmental condition characterized by restrictive and repetitive behaviors, alongside deficits in social interaction and communication. The etiology of ASD is largely unknown but is strongly linked to genetic variants in neuronal cell adhesion molecules (CAMs), cell-surface proteins that have important roles in neurodevelopment. A combination of environmental and genetic factors are believed to contribute to ASD pathogenesis.

View Article and Find Full Text PDF

Autism spectrum disorder (ASD) is characterized by impaired social interaction, language delay and repetitive or restrictive behaviors. With increasing prevalence, ASD is currently estimated to affect 0.5-2.

View Article and Find Full Text PDF